investor.lantheus.comInvestor Relations | Lantheus Holdings, Inc.
investor.lantheus.com Profile
investor.lantheus.com
Maindomain:lantheus.com
Title:Investor Relations | Lantheus Holdings, Inc.
Description:Learn more about the medical imaging solutions that Lantheus provides for the best possible degree of definition contrast and detailed information
Discover investor.lantheus.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
investor.lantheus.com Information
Website / Domain: |
investor.lantheus.com |
HomePage size: | 62.855 KB |
Page Load Time: | 0.729948 Seconds |
Website IP Address: |
184.28.219.57 |
Isp Server: |
Akamai Technologies Inc. |
investor.lantheus.com Ip Information
Ip Country: |
United States |
City Name: |
Fremont |
Latitude: |
37.548271179199 |
Longitude: |
-121.98857116699 |
investor.lantheus.com Keywords accounting
investor.lantheus.com Httpheader
Accept-Ranges: bytes |
Content-Encoding: gzip |
Content-Language: en |
Content-Type: text/html; charset=UTF-8 |
device: desktop |
ETag: "1597573998" |
Expect-CT: max-age=0, report-uri="/report-expect-ct-violation" |
Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same |
Last-Modified: Sun, 16 Aug 2020 10:33:18 GMT |
Link: http://investor.lantheus.com/; rel="shortlink", http://investor.lantheus.com/; rel="canonical", https://investor.lantheus.com/investor-relations; rel="alternate"; hreflang="en", https://investor.lantheus.com/investor-relations; rel="revision" |
Referrer-Policy: no-referrer-when-downgrade |
Server: nginx |
X-Age: 0 |
X-Content-Type-Options: nosniff |
X-Drupal-Dynamic-Cache: UNCACHEABLE |
X-Frame-Options: SAMEORIGIN |
X-Generator: Drupal 8 (https://www.drupal.org) |
X-Request-ID: v-e6828936-dfab-11ea-9ac4-076bc13c1725 |
X-UA-Compatible: IE=edge |
X-XSS-Protection: 1; mode=block |
Content-Length: 13220 |
X-EdgeConnect-MidMile-RTT: 0, 42 |
X-EdgeConnect-Origin-MEX-Latency: 512, 512 |
Cache-Control: public, max-age=0, s-maxage=1800 |
Expires: Sun, 16 Aug 2020 10:33:19 GMT |
Date: Sun, 16 Aug 2020 10:33:19 GMT |
Connection: keep-alive |
Vary: Accept-Encoding |
Set-Cookie: DrupalVisitorMobile=0; path=/; Secure; HttpOnly |
Strict-Transport-Security: max-age=15768000 ; preload |
investor.lantheus.com Meta Info
charset="utf-8"/ |
content="Lantheus Holdings, Inc." property="og:site_name"/ |
content="website" property="og:type"/ |
content="no-referrer" name="referrer"/ |
content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
content="width" name="MobileOptimized"/ |
content="true" name="HandheldFriendly"/ |
content="width=device-width, initial-scale=1.0" name="viewport"/ |
184.28.219.57 Domains
investor.lantheus.com Similar Website
Domain |
WebSite Title |
ir.p10holdings.com | Investor Relations | P10 Holdings |
investor.windstream.com | Windstream Holdings, Inc. - Investor Relations |
ir.qalaaholdings.com | Investor Relations - Qalaa Holdings IR |
investor.onemainfinancial.com | Investor Information - OneMain Holdings, Inc. |
investor.marketaxess.com | Investor Relations - MarketAxess Holdings, Inc. |
investor.pandora.com | Sirius XM Holdings Inc. - Investor Overview |
ir.brainchipinc.com | Investor Relations :: BrainChip Holdings Ltd. |
ir.wns.com | Investor Overview | WNS Holdings Ltd. |
ir.agritekholdings.com | Investor Relations | Agritek Holdings, Inc. IR |
investor.lantheus.com | Investor Relations | Lantheus Holdings, Inc. |
investor.jalexandersholdings.com | J. Alexander´s Holdings, Inc. Investor Relations | |
ir.hill-rom.com | Investor Relations, Hill-Rom Holdings, Inc. |
investor.ashland.com | Investor Relations | Ashland Global Holdings Inc. |
investors.sportsmanswarehouse.com | Investor Relations | Sportsman's Warehouse Holdings, Inc. |
ir.compassequity.com | Investor Relations | Compass Diversified Holdings |
investor.lantheus.com Traffic Sources Chart
investor.lantheus.com Alexa Rank History Chart
investor.lantheus.com Html To Plain Text
Skip to main navigation Contact Us Investors Media Careers About Us COVID-19 See the Difference Leadership History Corporate Citizenship Grants Locations Products Overview Overview DEFINITY ® VIALMIX ® PINSYNC ® TechneLite ® Xenon-133 Calidose™ Dispenser System NEUROLITE ® Thallium-201 QUADRAMET ® Cardiolite ® Gallium-67 Fludeoxyglucose F 18 Injection Manufacturing & Supply Chain Customer Service Customer Service FAQs Standard Conditions of Sale Reimbursement Radiochemical Products Radiochemical Products Cobalt-57 Lead-203 Gallium-67 Xenon-133 Patent Information Pipeline New Product Development Flurpiridaz F 18 LMI 1195 (CNA) Art of Imaging Overview History of Innovation Medical Imaging 101 Echocardiography Nuclear Imaging Contact Us Investors Media Careers Investor Relations Investor Relations Investor Overview Corporate Profile Press Releases SEC Filings Supplemental Financial Information Corporate Governance Board of Directors Stock Information Calendar of Events Presentations Information Requests FAQ IR Contact Investor Toolkit Print Page RSS Feeds E-mail Alerts Investor Relations Corporate Profile Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc. (“Lantheus”), which is a global leader in the development, distribution and commercialization of innovative diagnostic image agents and products. For 60 years, Lantheus has been dedicated to creating and providing pioneering medical imaging solutions to improve the treatment of human disease. Our agents and products assist physicians in the diagnosis of conditions affecting the heart, brain, lungs and other organs using echocardiography and nuclear imaging technologies. As Progenics joined the Lantheus family, we added a pipeline of radiotherapeutics, targeted PET imaging agents and small molecule therapeutics in the oncology space. Data provided by Nasdaq. Minimum 15 minutes delayed. In connection with the acquisition of Progenics, we are providing a single Form 8937 to our shareholders by posting such form to our website. A copy of the Form 8937 can be found here . Lantheus Investor Relations Team works to provide, shareholders, analysts and potential investors with timely, relevant and reliable information. We strive to make our press releases, scientific papers, and abstracts timely and accurate when issued. Subsequent events may affect their continued accuracy beyond the date of issuance and posting on the website. These documents may contain forward-looking statements. Actual results could vary dramatically as a result of known and unknown risks and uncertainties. Recent News More Date Title 08/12/20 Summary Toggle Lantheus Holdings, Inc. Announces FDA Approval of VIALMIX® RFID Device for DEFINITY® Summary Toggle Lantheus Holdings, Inc. Announces FDA Approval of VIALMIX® RFID Device for DEFINITY® NORTH BILLERICA, Mass. --(BUSINESS WIRE)--Aug. 12, 2020-- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc. , and a global leader in the development, manufacture and commercialization of innovative 07/30/20 Summary Toggle Lantheus Holdings, Inc. Reports Second Quarter 2020 Financial Results Summary Toggle Lantheus Holdings, Inc. Reports Second Quarter 2020 Financial Results Completed acquisition of Progenics Pharmaceuticals, Inc., adding robust portfolio of oncology therapeutics and diagnostics to pipeline Worldwide revenue of $66.0 million for the second quarter 2020, representing a decrease of 23.0% from the prior year period Net loss of $7.0 million for the second 07/23/20 Summary Toggle Lantheus Holdings to Host Second Quarter 2020 Earnings Conference Call on July 30, 2020 at 8:00 a.m. Eastern Time Summary Toggle Lantheus Holdings to Host Second Quarter 2020 Earnings Conference Call on July 30, 2020 at 8:00 a.m. Eastern Time NORTH BILLERICA, Mass. --(BUSINESS WIRE)--Jul. 23, 2020-- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call at 8:00 a.m. ET on Thursday, July 30, 2020 , to discuss its financial and operating results for the second quarter of 2020. 07/01/20 Summary Toggle Lantheus Holdings to Showcase the Potential of PyL™ Imaging Agent at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 Annual Meeting Summary Toggle Lantheus Holdings to Showcase the Potential of PyL™ Imaging Agent at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 Annual Meeting NORTH BILLERICA, Mass. --(BUSINESS WIRE)--Jul. 1, 2020-- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and commercialization of innovative Upcoming Events More There are currently no events to display. Receive E-mail Alerts Required fields denoted by an asterisk ( ). Alert type Lantheus Holdings, Inc. SEC Filing Alert Lantheus Holdings, Inc. Calendar Alert Lantheus Holdings, Inc. News Alert Email Contact Us Privacy Policy Legal Notice Compliance Suppliers/Vendors © 2020 Lantheus Medical Imaging, Inc. All rights reserved. Intended for U.S. Residents only. 331 Treble Cove Road, N. Billerica, MA 01862 Telephone: 1-800-362-2668 Use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy ....
investor.lantheus.com Whois
"domain_name": "LANTHEUS.COM",
"registrar": "Network Solutions, LLC",
"whois_server": "whois.networksolutions.com",
"referral_url": null,
"updated_date": [
"2019-12-07 08:04:01",
"2019-12-07 08:04:08"
],
"creation_date": "2008-02-04 16:56:19",
"expiration_date": "2021-02-04 16:56:19",
"name_servers": [
"NS10.DNSMADEEASY.COM",
"NS11.DNSMADEEASY.COM",
"NS12.DNSMADEEASY.COM",
"NS13.DNSMADEEASY.COM",
"NS14.DNSMADEEASY.COM",
"NS15.DNSMADEEASY.COM"
],
"status": "clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"emails": [
"abuse@web.com",
"tammy.martineau@lantheus.com"
],
"dnssec": "unsigned",
"name": "Lantheus Medical Imaging",
"org": "Lantheus Medical Imaging",
"address": "331 TREBLE COVE RD",
"city": "N BILLERICA",
"state": "MA",
"zipcode": "01862-2849",
"country": "US"